Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Business
·
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
CN
CitrixNews Staff
Originally reported by New York Times
Related Articles
Business
Hormuz disruptions hit China’s Christmas capital — and holiday spending
Christmas is still eight months away, but artificial tree maker Lou Liping is already worried about a bad holiday season...
CitrixNews Staff
·
1 hour ago
Business
How Trump's psychedelics executive order could unlock stalled cannabis reform
A White House executive order on psychedelics, signed by President Donald Trump on Saturday, aims to speed up research o...
CitrixNews Staff
·
1 hour ago
Business
The Guardian view on the EU and Israel: moving beyond mere exhortation | Editorial
Benjamin Netanyahu has brushed aside European concerns over Gaza, the West Bank and Lebanon. A tougher approach from Bru...
CitrixNews Staff
·
2 hours ago
Business
Lord Skidelsky obituary
Economic historian and politician who was a leading authority on the life and work of John Maynard KeynesIn the summer o...
CitrixNews Staff
·
2 hours ago